Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

ACTON, Mass./WEST WARWICK, R.I., February 14, 2023 – Bluejay Diagnostics, Inc.
(NASDAQ: BJDX) (“Bluejay”), and Blood Centers of America (BCA) today announced
that they have executed a collaborative agreement to develop commercial
relationships to serve unmet needs by utilizing the Symphony^TM Platform
in the blood and hospital markets. READ MORE